References
1. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev .
2009;89:381-410.
2. Argiles JM, Busquets S, Stemmler B and Lopez-Soriano FJ. Cancer
cachexia: understanding the molecular basis. Nat Rev Cancer .
2014;14:754-62.
3. Peixoto da Silva S, Santos JMO, Costa ESMP, Gil da Costa RM and
Medeiros R. Cancer cachexia and its pathophysiology: links with
sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle .
2020;11:619-635.
4. Sadeghi M, Keshavarz-Fathi M, Baracos V, Arends J, Mahmoudi M and
Rezaei N. Cancer cachexia: Diagnosis, assessment, and treatment.Crit Rev Oncol Hematol . 2018;127:91-104.
5. Ni J and Zhang L. Cancer Cachexia: Definition, Staging, and Emerging
Treatments. Cancer Manag Res . 2020;12:5597-5605.
6. Mattox TW. Cancer Cachexia: Cause, Diagnosis, and Treatment.Nutr Clin Pract . 2017;32:599-606.
7. Argiles JM, Lopez-Soriano FJ, Stemmler B and Busquets S. Therapeutic
strategies against cancer cachexia. Eur J Transl Myol .
2019;29:7960.
8. Montalvo RN, Counts BR and Carson JA. Understanding sex differences
in the regulation of cancer-induced muscle wasting. Curr Opin
Support Palliat Care . 2018;12:394-403.
9. Zhong X and Zimmers TA. Sex Differences in Cancer Cachexia.Curr Osteoporos Rep . 2020;18:646-654.
10. Rosa-Caldwell ME and Greene NP. Muscle metabolism and atrophy: let’s
talk about sex. Biol Sex Differ . 2019;10:43.
11. Rausch V, Sala V, Penna F, Porporato PE and Ghigo A. Understanding
the common mechanisms of heart and skeletal muscle wasting in cancer
cachexia. Oncogenesis . 2021;10:1.
12. Yang W, Huang J, Wu H, Wang Y, Du Z, Ling Y, Wang W, Wu Q and Gao W.
Molecular mechanisms of cancer cachexiainduced muscle atrophy (Review).Mol Med Rep . 2020;22:4967-4980.
13. Judge SM, Nosacka RL, Delitto D, Gerber MH, Cameron ME, Trevino JG
and Judge AR. Skeletal Muscle Fibrosis in Pancreatic Cancer Patients
with Respect to Survival. JNCI Cancer Spectr . 2018;2:pky043.
14. Light N and Champion AE. Characterization of muscle epimysium,
perimysium and endomysium collagens. Biochem J . 1984;219:1017-26.
15. Goetsch SC, Hawke TJ, Gallardo TD, Richardson JA and Garry DJ.
Transcriptional profiling and regulation of the extracellular matrix
during muscle regeneration. Physiol Genomics . 2003;14:261-71.
16. Devine RD, Bicer S, Reiser PJ, Velten M and Wold LE.
Metalloproteinase expression is altered in cardiac and skeletal muscle
in cancer cachexia. Am J Physiol Heart Circ Physiol .
2015;309:H685-91.
17. Chakravarthy A, Khan L, Bensler NP, Bose P and De Carvalho DD.
TGF-beta-associated extracellular matrix genes link cancer-associated
fibroblasts to immune evasion and immunotherapy failure. Nat
Commun . 2018;9:4692.
18. Caja L, Dituri F, Mancarella S, Caballero-Diaz D, Moustakas A,
Giannelli G and Fabregat I. TGF-beta and the Tissue Microenvironment:
Relevance in Fibrosis and Cancer. Int J Mol Sci . 2018;19.
19. Tsuda T. Extracellular Interactions between Fibulins and
Transforming Growth Factor (TGF)-beta in Physiological and Pathological
Conditions. Int J Mol Sci . 2018;19.
20. Alves MJ, Figueredo RG, Azevedo FF, Cavallaro DA, Neto NI, Lima JD,
Matos-Neto E, Radloff K, Riccardi DM, Camargo RG, De Alcantara PS, Otoch
JP, Junior ML and Seelaender M. Adipose tissue fibrosis in human cancer
cachexia: the role of TGFbeta pathway. BMC Cancer . 2017;17:190.
21. White JP. IL-6, cancer and cachexia: metabolic dysfunction creates
the perfect storm. Transl Cancer Res . 2017;6:S280-S285.
22. Mortreux M, Rosa-Caldwell ME, Stiehl ID, Sung DM, Thomas NT, Fry CS
and Rutkove SB. Hindlimb suspension in Wistar rats: Sex-based
differences in muscle response. Physiol Rep . 2021;9:e15042.
23. Rosa-Caldwell ME, Lim S, Haynie WS, Brown JL, Lee DE, Dunlap KR,
Jansen LT, Washington TA, Wiggs MP and Greene NP. Mitochondrial
aberrations during the progression of disuse atrophy differentially
affect male and female mice. J Cachexia Sarcopenia Muscle .
2021;12:2056-2068.
24. Rosa-Caldwell ME, Lim S, Haynie WA, Brown JL, Deaver JW, Morena Da
Silva F, Jansen LT, Lee DE, Wiggs MP, Washington TA and Greene NP.
Female mice may have exacerbated catabolic signalling response compared
to male mice during development and progression of disuse atrophy.J Cachexia Sarcopenia Muscle . 2021;12:717-730.
25. White JP, Baltgalvis KA, Sato S, Wilson LB and Carson JA. Effect of
nandrolone decanoate administration on recovery from bupivacaine-induced
muscle injury. J Appl Physiol (1985) . 2009;107:1420-30.
26. Counts BR, Fix DK, Hetzler KL and Carson JA. The Effect of Estradiol
Administration on Muscle Mass Loss and Cachexia Progression in Female
Apc (Min/+) Mice. Front Endocrinol (Lausanne) . 2019;10:720.
27. Lim S, Deaver JW, Rosa-Caldwell ME, Haynie WS, Morena da Silva F,
Cabrera AR, Schrems ER, Saling LW, Jansen LT, Dunlap KR, Wiggs MP,
Washington TA and Greene NP. Development of metabolic and contractile
alterations in development of cancer cachexia in female tumor-bearing
mice. J Appl Physiol (1985) . 2022;132:58-72.
28. Brown JL, Rosa-Caldwell ME, Lee DE, Blackwell TA, Brown LA, Perry
RA, Haynie WS, Hardee JP, Carson JA, Wiggs MP, Washington TA and Greene
NP. Mitochondrial degeneration precedes the development of muscle
atrophy in progression of cancer cachexia in tumour-bearing mice.J Cachexia Sarcopenia Muscle . 2017;8:926-938.
29. Brown JL, Lee DE, Rosa-Caldwell ME, Brown LA, Perry RA, Haynie WS,
Huseman K, Sataranatarajan K, Van Remmen H, Washington TA, Wiggs MP and
Greene NP. Protein imbalance in the development of skeletal muscle
wasting in tumour-bearing mice. J Cachexia Sarcopenia Muscle .
2018;9:987-1002.
30. Perry RA, Brown LA, Haynie WS, Brown JL, Rosa-Caldwell ME, Lee DE,
Greene NP and Washington TA. Cardiac hypertrophy in sarcopenic obese
C57BL/6J mice is independent of Akt/mTOR cellular signaling.Experimental gerontology . 2018;111:122-132.
31. Goossens GH, Jocken JWE and Blaak EE. Sexual dimorphism in
cardiometabolic health: the role of adipose tissue, muscle and liver.Nat Rev Endocrinol . 2021;17:47-66.
32. Nye GA, Sakellariou GK, Degens H and Lightfoot AP. Muscling in on
mitochondrial sexual dimorphism; role of mitochondrial dimorphism in
skeletal muscle health and disease. Clin Sci (Lond) .
2017;131:1919-1922.
33. Fernandes LG, Tobias GC, Paixao AO, Dourado PM, Voltarelli VA and
Brum PC. Exercise training delays cardiac remodeling in a mouse model of
cancer cachexia. Life Sci . 2020;260:118392.
34. Schmidt SF, Rohm M, Herzig S and Berriel Diaz M. Cancer Cachexia:
More Than Skeletal Muscle Wasting. Trends Cancer . 2018;4:849-860.
35. Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND and Zhao YY. New
insights into TGF-beta/Smad signaling in tissue fibrosis. Chem
Biol Interact . 2018;292:76-83.
36. Walton KL, Johnson KE and Harrison CA. Targeting TGF-beta Mediated
SMAD Signaling for the Prevention of Fibrosis. Front Pharmacol .
2017;8:461.
37. Ma TT and Meng XM. TGF-beta/Smad and Renal Fibrosis. Adv Exp
Med Biol . 2019;1165:347-364.
38. Floege J. Antagonism of canonical Wnt/beta-catenin signaling: taking
RAS blockade to the next level? J Am Soc Nephrol . 2015;26:3-5.
39. Qiao X, Rao P, Zhang Y, Liu L, Pang M, Wang H, Hu M, Tian X, Zhang
J, Zhao Y, Wang XM, Wang C, Yu H, Guo F, Cao Q, Wang Y, Wang YM, Zhang
GY, Lee VW, Alexander SI, Zheng G and Harris DCH. Redirecting TGF-beta
Signaling through the beta-Catenin/Foxo Complex Prevents Kidney
Fibrosis. J Am Soc Nephrol . 2018;29:557-570.
40. Guerrero F, Herencia C, Almaden Y, Martinez-Moreno JM, Montes de Oca
A, Rodriguez-Ortiz ME, Diaz-Tocados JM, Canalejo A, Florio M, Lopez I,
Richards WG, Rodriguez M, Aguilera-Tejero E and Munoz-Castaneda JR.
TGF-beta prevents phosphate-induced osteogenesis through inhibition of
BMP and Wnt/beta-catenin pathways. PLoS One . 2014;9:e89179.
41. Ma H, Wei Y, Leng Y, Li S, Gao L, Hu H, Chen L, Wang F, Xiao H, Zhu
C and Liang C. TGF-beta1-induced expression of Id-1 is associated with
tumor progression in gastric cancer. Med Oncol . 2014;31:19.